TW200514850A - Method of evaluating risk for viral infection - Google Patents
Method of evaluating risk for viral infectionInfo
- Publication number
- TW200514850A TW200514850A TW093129864A TW93129864A TW200514850A TW 200514850 A TW200514850 A TW 200514850A TW 093129864 A TW093129864 A TW 093129864A TW 93129864 A TW93129864 A TW 93129864A TW 200514850 A TW200514850 A TW 200514850A
- Authority
- TW
- Taiwan
- Prior art keywords
- viral infection
- evaluating risk
- single nucleotide
- nucleotide polymorphisms
- risk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003346211 | 2003-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200514850A true TW200514850A (en) | 2005-05-01 |
Family
ID=34419499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093129864A TW200514850A (en) | 2003-10-03 | 2004-10-01 | Method of evaluating risk for viral infection |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4533978B2 (zh) |
TW (1) | TW200514850A (zh) |
WO (1) | WO2005033338A1 (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69841514D1 (de) * | 1997-05-07 | 2010-04-01 | Schering Corp | Menschliche Toll-Like-Rezeptorproteine, zugehörige Reagenzien und Verfahren |
US6740487B1 (en) * | 1999-06-10 | 2004-05-25 | University Of Iowa Research Foundation | Variant TLR4 nucleic acid and uses thereof |
US6913888B2 (en) * | 2001-12-11 | 2005-07-05 | Duke University | Toll-like receptor 4 mutations |
-
2004
- 2004-10-01 TW TW093129864A patent/TW200514850A/zh unknown
- 2004-10-04 JP JP2005514484A patent/JP4533978B2/ja not_active Expired - Fee Related
- 2004-10-04 WO PCT/JP2004/014605 patent/WO2005033338A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP4533978B2 (ja) | 2010-09-01 |
JPWO2005033338A1 (ja) | 2007-11-15 |
WO2005033338A1 (ja) | 2005-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG142154A1 (en) | Methods for genomic analysis | |
WO2002018641A3 (en) | Detection of cyp3a4 and cyp2c9 polymorphisms | |
AU2003299817A8 (en) | Genetic polymorphisms associated with stenosis, methods of detection and uses thereof | |
WO2003097794A3 (en) | Universal-tagged oligonucleotide primers and methods of use | |
AU2003241311A8 (en) | Simple catalytic dna biosensors for ions based on color changes | |
SI1730315T1 (sl) | Polimorfizmi v genu NOD2/CARD15 | |
WO2001047944A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
UA84284C2 (ru) | Способы лечения, профилактики и диагностики инфекции helicobacter cerdo | |
WO2001075174A3 (en) | Detection and typing of human papillomavirus using pna probes | |
AU2003293141A1 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
WO2004043232A3 (en) | Methods for identifying risk of melanoma and treatments thereof | |
WO2000029623A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
IL158159A0 (en) | NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-21 GENE | |
TW200514850A (en) | Method of evaluating risk for viral infection | |
WO2001023410A3 (en) | Drug target isogenes: polymorphisms in the interleukin 13 gene | |
WO2001048245A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
AU2002214041A1 (en) | Diagnosis of diseases associated with the human c-mos gene | |
WO2002080755A3 (en) | Kits and methods for assessing oxidative stress | |
WO2001058914A3 (en) | Haplotypes of the interleukin 15 gene | |
WO2001079234A3 (en) | Haplotypes of the apoe gene | |
WO2002053018A3 (en) | Method of detecting polymorphisms associated with breast carcinoma in mhc genes | |
WO2002072883A3 (de) | Nukleotidträger zur diagnose und therapie oraler erkrankungen | |
WO2001011010A3 (en) | Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene | |
WO2000029622A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
WO2001079240A3 (en) | Haplotypes of the rangap1 gene |